9 Newly Approved Novel Drugs
It's been a busy year for the FDA.
4. Siliq (brodalumab), Valeant Pharmaceuticals
Indications: A human interleukin-17 receptor A (IL-17RA) antagonist used to manage moderate-to-severe plaque psoriasis. It is indicated for adultcandidates for systemic therapy or phototherapy who have failed to respond or who have stopped responding to other systemic therapies.
Dosage: 210 mg by subcutaneous injection at Weeks 0, 1, and 2 followed by 210 mg every 2 weeks.
Contraindications: Crohn’s disease